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Transient NADH Responses to Cyanide Related to the Absorption Proper-
ties of Intact Cardiac Tissue
Iffath A. Ghouri, Ole J. Kemi, Aileen Rankin, Godfrey L. Smith.
Measurements of the intrinsically fluorescent metabolite NADH can be used to
monitor mitochondrial redox state in isolated cardiomyocytes. NADH was 2P
excited at 720nm and fluorescence was collected at 435-485nm. Calibration of
the fluorescence signal with the metabolic inhibitors FCCP and cyanide en-
abled establishment of mitochondrial redox state. Treatment with 2mM FCCP
induces maximally oxidised mitochondrial states, causing NADH fluorescence
to decrease to minimal levels. Conversely, treatment with 2mM cyanide in-
duces maximally reduced mitochondrial states, resulting in NADH fluores-
cence increasing to maximal levels.
Similar measurements were performed in a Langendorff perfused whole heart
preparation. However, unlike with isolated cells, the cyanide response was tran-
sient in nature. A possible reason for this could be the influence of inner-filter
effects in thick tissue preparations. Investigation into the effects of cyanide on
tissue transmission properties was carried out using a blue LED with 450-
490nm emission (corresponding to NADH emission). Cyanide perfusion
caused light transmission at these wavelengths to decrease in the left ventricle
(LV), but increase in the right ventricle (RV). The most likely sources of ab-
sorption at these wavelengths are from myoglobin and FAD (oxidised). Spec-
troscopic examination revealed that light absorption by myoglobin at
wavelengths corresponding to NADH emission increased upon cyanide appli-
cation (due to binding of cyanide to myoglobin). FAD absorption decreased
when reduced to FADH2, mimicking the effects of cyanide on mitochondrial
FAD in the tissue. Thus, the additional complications caused by inner-filter ef-
fects and other optical artefacts may explain the transient NADH response to
cyanide observed in our intact tissue preparations. The balance between myo-
globin and FAD concentrations are likely to explain the differing transmission
responses to cyanide in the LV and RV, with LV tissue containing more
myoglobin.
1594-Pos Board B504
Drosophila as a Model for Amyloid Induced Cardiac Dysfunction
Girish C. Melkani, Karen Ocorr, Rolf Bodmer, Sanford I. Bernstein.
Several human diseases are associated with the expression of mutated, mis-
folded and aggregation-prone amyloid proteins. Huntington’s disease (HD) is
caused by mutation in the Huntingtin protein that results in an expanded poly-
glutamine (PQ) repeat and formation of amyloid-like inclusions. The length of
the PQ-repeat is also important in the progression of disease. Recent evidence
indicates that patients with HD demonstrate a greater occurrence of cardiovas-
cular events but very little is known as to how HD leads to cardiac failure. Our
study uses the model organism Drosophila melanogaster to explore PQ
amyloid-induced cardiac dysfunction. Using the UAS-Gal4 expression system,
we express short and long UAS-PQ in the Drosophila heart using a cardiac spe-
cific driver (Hand-Gal4). Expression of extended PQ (UAS-97Q) resulted in
severe cardiac defects. However, no such defects were seen upon expression
of short PQ (UAS-25Q) under similar conditions. For example, the arrhythmic-
ity index (overall measure of cardiac arrhythmia) of 1 week old PQ-97 fly
hearts was twice that of the same age flies expressing PQ-25. Further, more
progressive cardiac dysfunction (six fold increase in arrhythmicity index)
was observed after 3 weeks in fly hearts expressing PQ-97 compared to same
age fly hearts expressing PQ-25. Additionally, heart period, diastolic and sys-
tolic intervals of 1 and 3 week old fly hearts expressing PQ-97 were higher
compared to same age flies expressing PQ25. Our results show that expression
of PQ-97 causes progressive cardiac dysfunction. We are currently examining
structural defects and possible amyloid aggregates in the cardiac tube that
arises upon expression of extended PQ. Our study organism Drosophila, with
its high degree of conservation relative to the human genome and many tech-
niques to manipulate its gene expression, will be an excellent model for under-
standing the mechanism of cardiac failure in HD patients.
1595-Pos Board B505
Altered Force Development in Response to Calcium and Isopreterenol
in Cardiac Muscle from Gravin Knock-Out (AKAP12) Mice
Wei Dong Gao, Zhitao Li, Cori Wijaya, Bradley K. McConnell.
Gravin (AKAP12), one of the A-Kinase-Binding-Proteins (AKAPs), serves as
a scaffold protein linking b2-adrenergic receptor (b2-AR), phosphatase 2B and
several kinases including Protein Kinase A (PKA) and Protein Kinase C (PKC).
The presence of gravin facilitates signal transduction of b2-AR and thus affects
cardiac excitation-contraction coupling. Here, we test whether cardiac contrac-
tion is also affected in gravin knock-out (gravin-KO) mice. Trabeculae or smallpapillary muscles from the right ventricles were mounted between a force trans-
ducer and a motor arm, and superfused with K-H solution (pH 7.4) at room tem-
perature. Developed force increased as external Ca2þ ([Ca2þ]o) was raised from
1 to 10 mmol/L in both gravin-KO and widetype (WT) muscles. Developed
force increased in a dose dependent manner as [Ca2þ]o was raised. In gravin-
KO muscles, lower [Ca2þ]o (>3.0 mmol/L) caused higher but insignificant
force development as compared with WT muscles. At higher [Ca2þ]os, devel-
oped forces remained largely flat and significantly lower in gravin-KO muscles
as [Ca2þ]o was increased up to 10.0 mmol/L. Similarly, developed force in-
creased as doses of isopreterenol (ISO) increased (0.05 nmol/L to 200 nmol/
L) in both groups of muscles. However, force response started to blunt in
gravin-KO muscle at ISO doses >5 nmol/L and became significantly lower
at ISO does >50 nmol/L. These results show that gravin-KO muscles maintain
their response to both Ca2þ and ISO, with reduced capacity at higher doses,
suggesting that gravin plays an important modulatory role in the argumentation
of force by Ca2þ and b2-AR stimulation. Ongoing experiments are focused on
changes in intracellular Ca2þ and myofilament Ca2þ responsiveness in gravin-
KO mice.
1596-Pos Board B506
Gsk Mediates Rapid Estrogen-Induced Cardioprotection Without Akt
Activation After Ischemia/Reperfusion
Jean Chrisostome Bopassa, Harpreet Singh, Ligia Toro, Enrico Stefani.
We investigated the role of Glycogen Synthase Kinase (GSK-3b), Erk and Akt
activation in rapid 17ß-estradiol (E2)-induced cardioprotection after ischemia/
reperfusion.
Isolated mice hearts were retrograde-perfused using the Langendorff system at
37oC. Hearts were perfused with oxygenated (95% O2 and 5% CO2) Krebs
Henseleit solution (control) or with E2 (40 nM). After 20 min perfusion, hearts
were subjected to 20 min global normothermic ischemia followed by 40 min
reperfusion. Cardiac function was recorded throughout the experiment and at
the end of the reperfusion (60 min) infarct size was evaluated by TTC staining.
After 10 min of reperfusion, mitochondria were isolated to assess the calcium
load required to induce the opening of mitochondria permeability transition
pore (mPTP) referred as Calcium Retention Capacity (CRC), and whole heart
lysates were prepared for Western blot analysis of pGSK-3b, pErk, pAkt and
vinculin.
The E2-treated group had significantly increased CRC (287517 vs. 180512
nM/mg mitochondrial protein p<0.05), reduced infarct size (2653% vs.
5452.8% p<0.001) and improved heart functional recovery (RPP,
119005467 vs. 59115318 mmHgxbeats/min, p<0.001) when compared to
control. GSK-3b and Erk1/2 phosphorylation levels were significantly in-
creased in E2-treated hearts (~3 and ~2 fold, respectively) without significant
changes in Akt phosphorylation. These results indicate that rapid E2-induced
cardioprotection inhibits the mPTP opening resulting in a reduction of the in-
farct size and improvement of heart function recovery via GSK-3b and Erk
phosphorylation independently of Akt phosphorylation. Supported by NIH.
1597-Pos Board B507
Loss of Rapid Estrogen-Induced Cardioprotection in GPER-/- Mice After
Ischemia and Reperfusion
Jean Chrisostome Bopassa, L.M. Frederik Leeb-Lundberg, Bjo¨rn Olde,
Ligia Toro, Enrico Stefani.
Several studies have demonstrated that G protein coupled receptor 30
(GPER) can directly bind to 17ß-estradiol (E2) mediating its action. Using
pharmacological tools, we previously identified GPER as possible mediator
of E2-mediated cardioprotection in male wild type (WT) mice subjected to is-
chemia/reperfusion. Here, we investigate this point further using GPER-/-
mice.Isolated hearts from male WT (C57BL/6NCrL) or GPER-/- mice were
perfused using the Langendorff technique with oxygenated (95% O2 and 5%
CO2) Krebs Henseleit buffer (control) containing or not 40 nM E2. After 20
min of perfusion, hearts were subjected to 18 min global normothermic ische-
mia followed by 60 min reperfusion. Heart function was continuously recorded
and myocardial necrosis was evaluated by TTC staining after the reperfusion.
Mitochondria were isolated after 10 minutes of reperfusion to assess the cal-
cium load required to induce opening of mitochondria permeability transition
pore referred as Calcium Retention Capacity (CRC). In WT mice, E2 treatment
induced a much better recovery of heart function when compared with un-
treated hearts (RPP, 119005467 vs. 59115318 mmHgxbeats/min,
p<0.001). In contrast, E2 treatment had no beneficial action in GPER-/-
mice. No functional differences between E2-treated and control were found
(RPP, 63705655 vs. 62005380 mmHgxbeats/min). Similarly, the infarct
size decreased significantly in WT hearts after E2-treatment (2653% vs.
5452.8% p<0.001) but this protective infarct reduction by E2 treatment was
not observed in GPER-/- hearts (4655% vs. 5054%). A similar pattern was
found with CRC. E2 treatment in WT hearts significantly increased the
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p<0.05), but it had no effect on CRC from mitochondria of GPER-/- hearts
(170533 vs. 16757 nM/mg mitochondrial protein). These results conclu-
sively demonstrate that GPER plays an important role in mediating rapid
E2-induced cardioprotection after ischemia/reperfusion. Supported by NIH.
1598-Pos Board B508
Validation of Reperfusion Duration for Myocardial Infarction Assessment
in the Langendorff Ischemia Model of Isolated Mouse Heart
Jean Chrisostome Bopassa, Ligia Toro, Enrico Stefani.
Introduction: Perfused isolated heart is a widely used ex-vivo organ model as it
allows rigorous control of parameters what is not readily achievable by an in
vivo model. However, there is disagreement on the reperfusion duration to as-
sess the myocardial infarction by TTC staining. Many authors have used long
reperfusion times (~120 min) in conditions where the hearts during ischemia
were suspended in air water-jacketed chamber maintained at37C. Others
have determined myocardial infarction with short reperfusion durations
(30-40min) where the hearts were submerged in a normothermic physiological
solution. In this work where hearts were immersed in Krebs Henseleit (KH) so-
lution during ischemia we demonstrated that a reperfusion duration of 40 min is
adequate to determine infarct size after ischemia as longer reperfusion times of
60 and 90 min showed the same maximal infarct size.
Methods and Result:We compared different reperfusion durations (40, 60 and
90 min) of isolated mice hearts immersed in KH buffer after 18 min of normo-
thermic ischemia. Hearts were perfused using Langendorff apparatus with KH
buffer oxygenated with 95% O2 þ 5% CO2 at37C. The heart function was
recorded and myocardial infarction assessed by TTC staining at the end of
reperfusion. Our data show no significant difference between the groups reper-
fused for 40, 60 or 90 min in infarct size and heart function recovery.
Conclusion: These results indicate that when the isolated mice hearts are im-
mersed in a normothermic physiological solution during ischemia, reperfusion
for 40 min is sufficient to reach the maximum infarction.
1599-Pos Board B509
Ivabradine and Mechanical Unloading Increase Sarcoplasmic Reticulum
Calcium Content in a Rodent Model of Heart Failure
Manoraj Navaratnarajah, Carin van Doorn, Urszula Siedlecka,
Michael Ibrahim, Ajay Gandhi, Adarsh Shah, Magdi H. Yacoub,
Cesare M. Terracciano.
Improvements in Ca2þ handling, and sarcoplasmic reticulum (SR) Ca2þ
regulation in particular, are associated with myocardial recovery in patients
with end stage heart failure (HF) treated with left ventricular assist devices
(LVAD). Ivabradine (IV), a novel heart rate reducing agent has been shown to
have positive Ca2þ regulatory effects in rodent HF, and is used in human HF ther-
apy; however, the effects of IV during LVAD treatment have not been studied.
We studied the chronic effects of IV on cellular Ca2þ handling during mechan-
ical unloading (MU) of HF hearts. HF was induced by left coronary artery
ligation and was characterized by reduced ejection fraction (EF), smaller
Ca2þ transient amplitude (CaT) and reduced SR Ca2þ content compared to
age matched sham operated animals (SH). MU (4 weeks) was achieved by
heterotopic abdominal heart transplantation and IV (10mg/kg/day) was admin-
istered for 4 weeks. Isolated ventricular myocytes were loaded with Indo-1 AM
and field stimulated at 1 Hz.
CaT was significantly elevated in the MUþIV group (indo-1 ratio units):
MUþIV: 0.25 5 0.06 (n=45) p< 0.001 vs MU: 0.18 5 0.05 (n=40), and
p<0.001 vs SH: 0.175 0.05 (n=45)). IV augmented SR Ca2þ content in com-
bination with MU compared with MU alone and to a level even greater than
SH: SR Ca2þ content (indo-1 ratio units): MUþIV: 0.27 5 0.07 (n=45) p<
0.05 vs MU: 0.245 0.05 (n=40), and p<0.001 vs SH: 0.225 0.07 (n=45))
Our results show that IV treatment combined with mechanical unloading
induces a larger increase of Ca2þ transient amplitude and SR Ca2þ content
compared with mechanical unloading alone. These effects may be exploited
to enhance myocardial recovery in patients receiving LVAD therapy for HF.
1600-Pos Board B510
Bioenergetic Supply and Demand in the Cardiomyocyte
Edmund J. Crampin.
The mechanisms that regulate the control of energy demand and supply in the
myocardium are crucial for maintaining normal cardiac function. Although
a number of mechanisms have been proffered by which mitochondrial supply
of ATP can change to match varying workload in the myocardium, identifying
the underlying regulatory pathways remains controversial.
We describe an approach to studying this problem in which thermodynamically
consistent mathematical models of the key energy-consuming processes in the
cardiomyocyte (sarcoplasmic endoplasmic reticulum calcium ATPase
(SERCA)[1], sodium pump[2] and the acto-myosin cross-bridge cycle[3]) arecoupled to a model of mitochondrial ATP production within a whole-cell mod-
elling framework for cardiac excitation-contraction coupling[4].
We use the model to investigate the metabolic stability hypothesis, wherein en-
ergy demand-supply homeostasis is maintained despite negligible variation in
metabolite concentrations at varying cardiac workloads. We find that under
physiological workloads cellular metabolite concentrations do not change
significantly with increasing workload if a proposed feedback of inorganic
phosphate onto mitochondrial oxidative phosphorylation is present, consistent
with the proposition that Pi-regulation alone is sufficient to maintain metabolic
homeostasis in the absence of other regulatory mechanisms.
Finally, we use our model to address the empirically observed linearity of the
cardiac ATP vs. Force-Length-Area curve (the cellular equivalent of the VO2
vs. Pressure-Volume-Area relationship). We show that the apparent linearity
arises from the near irreversibility of the cross-bridge cycle, but that the linear
relationship may disappear at cardiac workloads high enough that cellular
metabolite concentrations start to vary.
[1] Biophysical Journal 96, 2029-2042, 2009
[2] American Journal of Physiology, Heart and Circulatory Physiology 293,
H3036-H3045, 2007
[3] Biophysical Journal 98, 267-276, 2010
[4] Biophysical Journal 90, 3074-3090, 2006
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Stimulation of Cardiac Neoangiogenesis by Estrogen Therapy is One of the
Key Mechanisms in Reversing Advanced Heart Failure
Andrea Iorga, Rod Partow-Navid, Humann Matori, Rangarajan Nadadur,
Jingyuan Li, Soban Umar, Mansoureh Eghbali.
Estrogen(E2) has been shown to regulate angiogenesis in different tissues, but it
is still not known if E2 could stimulate angiogenesis in the heart. Recently, we
showed that E2 rescues advanced heart failure by reversing the myocardial
contractile deficiency and restoring ejection fraction from ~30% to ~55%.
Here we examined whether stimulation of angiogenesis in the heart is a mech-
anism involved in the E2-induced rescue of HF. Trans-aortic constriction(TAC)
procedure was used to induce HF. Once the ejection fraction(EF) reached
~30%, one group of mice was sacrificed and the other two groups were treated
with E2(30 mg/kg/day, n=16), or E2 plus the angiogenesis inhibitor TNP-470
(TNP, 30 mg/kg, n=4) for 10 days. Serial echocardiography, real-time PCR
and immunocytochemistry were performed. RT-PCR showed that the transcript
levels of two markers of angiogenesis, vascular endothelial growth factor
(VEGF) and hypoxia-inducible factor-1a(HIF1a), were ~10 fold downregulated
in HF(0.1750.06 for VEGF and 0.2650.01 for HiF1a; normalized to CTRL).
E2 treatment was not only able to reverse VEGF and HIF1a transcript level
downregulation observed in HF, but to even upregulate both transcripts 3
fold higher than in healthy controls(3.2450.1 for VEGF and 3.1650.09 for
HIF1a). Quantification of capillary density also revealed that E2 therapy not
only completely reversed the loss of capillaries in HF, but significantly en-
hanced capillary density by ~ 4 fold compared to HF(2.8350.14 in E2 vs.
0.6650.07 in HF, normalized to CTRL). Interestingly, E2 failed to rescue
HF in the presence of TNP-470 (E2þTNP group) as EF (29.352.1%) was
not significantly improved after 10 days of therapy. The capillary density of
HF mice also did not improve in E2þTNP group(0.5350.07). These data
strongly support the vital role of angiogenesis in the rescue action of E2.
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Estrogen Receptor Beta, but Not Alpha, is the Key Player in Restoration
of Heart Function of Heart Failure Mice by Estrogen Therapy
Andrea Iorga, Rod Partow-Navid, Rangarajan Nadadur, Humann Matori,
Jingyuan Li, Soban Umar, Mansoureh Eghbali.
Recently we discovered that estrogen(E2) therapy can rescue advanced heart
failure(HF) induced by pressure overload in mice. Most of the biological
actions of estrogen are mediated thorough estrogen receptors alpha(ERa) and
beta(ERb), and both of these receptors are present in the heart. Here we inves-
tigated which estrogen receptor(s) are involved in the rescue by estrogen. We
used the transaortic constriction(TAC) procedure to induce HF. Once the ejec-
tion fraction(EF) reached ~30%, one group of animals was sacrificed(HF
group), and the other three groups received either 17b-estradiol (30 ug/kg/
day), selective ERa agonist (PPT, 0.625mg/kg/day), or selective ERb agonist
(DPN, 0.625mg/kg/day) for 10 days. Serial echocardiography was performed
and LV pressure was measured by direct catheterization before sacrifice. As ex-
pected, E2 rescued HF by restoring EF from 33.1751.12% to 53.0551.29%.
Interestingly, mice treated with ERb agonist had a significant improvement in
their EF from 33.1751.12% to 45.2552.1%(n=7), whereas the EF of mice
treated with ERa agonist did not improve at all(31.0952.3%, n=6). Similar
to EF, only fractional shortening of DPN-treated mice improved from
15.750.58% in HF to 21.9551.65% in DPN vs. 14.7251.24% in PPT).
Next, we examined the mechanical performance of the LV in mice treated
